ERBB2 and breast carcinoma: Referring to the literature, HER2 immunoscoring differs not only between breast carcinoma and upper gastrointestinal adenocarcinoma, but there are different criteria for biopsies and surgical specimens of EAC/gastric adenocarcinoma (Table 2).